Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Cash Flow Quality Index
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Cash Flow Quality Index of 4794.41x as of September 2025. Operating cash flow of CN¥281.88 Million exceeds net income of CN¥58.79K, indicating high earnings quality where cash backs reported profits. Explore 605033 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Shaanxi Meibang Pharmaceutical Group Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Shaanxi Meibang Pharmaceutical Group Co (605033) cash conversion ratio.
Annual Cash Flow Quality Index for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year earnings quality comparison for Shaanxi Meibang Pharmaceutical Group Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 7.61x | CN¥280.40 Million | CN¥36.86 Million | ▲ +30.8% |
| 2023 | 5.82x | CN¥334.79 Million | CN¥57.56 Million | ▲ +567.6% |
| 2022 | 0.87x | CN¥126.41 Million | CN¥145.09 Million | ▲ +200.7% |
| 2021 | -0.86x | CN¥-108.75 Million | CN¥125.74 Million | ▼ -190.9% |
| 2020 | 0.95x | CN¥74.88 Million | CN¥78.73 Million | ▼ -43.5% |
| 2019 | 1.68x | CN¥128.45 Million | CN¥76.26 Million | ▲ +489.3% |
| 2018 | 0.29x | CN¥16.96 Million | CN¥59.33 Million | ▼ -40.5% |
| 2017 | 0.48x | CN¥29.41 Million | CN¥61.22 Million | — |